The global MRSA antibiotic market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). The major factors attributing to the growth of the MRSA drugs market are the rise in the global prevalence of MRSA infections and increasing private and public funding for R&D with regards to novel anti-MRSA drugs. For instance, in January 2020, Wockhardt announced regulatory approval to two antibiotics EMROK (IV) and EMROK O (Oral), for acute bacterial skin and skin structure infections, including diabetic foot infections and concurrent bacteremia. The drugs will target superbug MRSA, which is a leading cause of rising antimicrobial resistance.
Browse the full report description of “Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotic Market Size, Share & Trends Analysis Report By Treatment Type (Vancomycin, Tetracycline, Linezolid, Daptomycin, and Lipopeptide), and By Distribution Channel (Online, Hospital Pharmacies, and Retail Pharmacies) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/mrsa-antibiotic-market
However, poor access to MRSA treatment and misdiagnoses of MRSA infections are the primary factors limiting the growth of the MRSA market. In addition, incorrect diagnoses of MRSA may result in inappropriate delivery and management of patient care, which in turn results in severe primary and secondary complications including death. All such factors may hinder the growth of the market during the forecast period.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Treatment Type
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Merck Group., Olon Active Pharmaceutical, Pfizer Inc., Viatris Inc., and Eli Lilly and Co.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global MRSA Antibiotic Market Report Segment
By Treatment Type
By Distribution Channel
Global MRSA Antibiotic Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/mrsa-antibiotic-market